000 | 01926 a2200529 4500 | ||
---|---|---|---|
005 | 20250517025523.0 | ||
264 | 0 | _c20160728 | |
008 | 201607s 0 0 eng d | ||
022 | _a1432-1440 | ||
024 | 7 |
_a10.1007/s00109-015-1277-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPradhan, Nirparaj | |
245 | 0 | 0 |
_aCurcumin nanoparticles inhibit corneal neovascularization. _h[electronic resource] |
260 |
_bJournal of molecular medicine (Berlin, Germany) _cOct 2015 |
||
300 |
_a1095-106 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta, Thoracic _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCornea _xdrug effects |
650 | 0 | 4 |
_aCorneal Keratocytes _xdrug effects |
650 | 0 | 4 |
_aCorneal Neovascularization _xdrug therapy |
650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aI-kappa B Proteins _xmetabolism |
650 | 0 | 4 |
_aInterleukin-1beta _xgenetics |
650 | 0 | 4 | _aLipopolysaccharides |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
650 | 0 | 4 |
_aPolyesters _xchemistry |
650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xgenetics |
700 | 1 | _aGuha, Rajdeep | |
700 | 1 | _aChowdhury, Sushovan | |
700 | 1 | _aNandi, Sudip | |
700 | 1 | _aKonar, Aditya | |
700 | 1 | _aHazra, Sarbani | |
773 | 0 |
_tJournal of molecular medicine (Berlin, Germany) _gvol. 93 _gno. 10 _gp. 1095-106 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00109-015-1277-z _zAvailable from publisher's website |
999 |
_c24808523 _d24808523 |